v3.22.2.2
EQUITY, SHARE-BASED COMPENSATION AND WARRANTS (Tables)
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of MedAvail Share-based Compensation Expense
The following table presents the Company's expense related to share-based compensation (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Share-based compensation$565 $365 $1,741 $948 
Schedule of Outstanding Option Awards Activity
The following table presents the Company's outstanding option awards activity during the nine months ended September 30, 2022:
(in thousands, except for share and per share amounts)Number of AwardsWeighted Average Exercise PriceWeighted Average Share Price on Date of ExerciseWeighted Average Fair ValueWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value
Outstanding, beginning of period2,848,903 $2.78 $1.44 $104 
Granted2,758,040 1.35 0.98 — 
Exercised/released— — — — 
Expired(117,730)1.99 1.08 
Forfeited(952,488)2.52 1.42 111 
Outstanding, end of period4,536,725 $1.93 $1.15 8.33$— 
Vested and exercisable, end of the period1,777,907 2.28 1.16 6.79— 
Vested and unvested exercisable, end of the period1,777,907 2.28 1.16 6.79— 
Vested and expected to vest, end of the period4,309,018 1.94 1.15 8.29— 
Schedule of Outstanding RSU Awards Activity
The following table presents the Company's outstanding restricted stock unit activity during the nine months ended September 30, 2022:

(in thousands, except for share and per share amounts)Number of AwardsWeighted Average Exercise PriceWeighted Average Share Price on Date of ExerciseWeighted Average Fair ValueWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value
Outstanding, beginning of period802,740 $— $2.78 $1,124 
Granted1,601,824 — 1.41 2,252 
Exercised/released(46,009)— $1.17 6.32 54 
Expired— — — — 
Forfeited(585,973)— 2.05 791 
Outstanding, end of period1,772,582 $— $1.69 4.93$1,376 
Vested and exercisable, end of the period— — — — 
Vested and unvested exercisable, end of the period— — — — 
Vested and expected to vest, end of the period1,628,975 — 1.69 4.921,264 
Schedule of Warrants Issued The terms for the warrants issued from the Private Placement were as follows:
September 30, 2022
Issue DateReason for issuanceTerm (years)Exercise Price (USD)
April 4, 2022Private Placement5$1.25 
July 1, 2022Private Placement5$1.25